{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:42:55Z","timestamp":1787020975490,"version":"build-2736575974"},"reference-count":18,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["j. immunotherapy cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40425-018-0468-x","type":"journal-article","created":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T10:02:34Z","timestamp":1544608954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Cryotherapy for nodal metastasis in NSCLC with acquired resistance to immunotherapy"],"prefix":"10.1136","volume":"6","author":[{"given":"Lucas C.","family":"Adam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junaid","family":"Raja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes M.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adebowale","family":"Adeniran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott N.","family":"Gettinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,12,12]]},"reference":[{"key":"468_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrc.2016.2","volume":"16","author":"NP Restifo","year":"2016","unstructured":"Restifo NP, Smyth MJ, Snyder A. Acquired resistance to immunotherapy and future challenges. Nat Rev Cancer. 2016;16:121\u20136.","journal-title":"Nat Rev Cancer"},{"key":"468_CR2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s40425-017-0284-8","volume":"5","author":"R Slovak","year":"2017","unstructured":"Slovak R, Ludwig JM, Gettinger SN, Herbst RS, Kim HS. Immuno-thermal ablations - boosting the anticancer immune response. J Immunother Cancer. 2017;5:78.","journal-title":"J Immunother Cancer"},{"key":"468_CR3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jhep.2016.10.029","volume":"66","author":"AG Duffy","year":"2017","unstructured":"Duffy AG, Ulahannan SV, Makorova-Rusher O, et al. Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma. J Hepatol. 2017;66:545\u201351.","journal-title":"J Hepatol"},{"key":"468_CR4","doi-asserted-by":"publisher","first-page":"5729","DOI":"10.1158\/1078-0432.CCR-16-0190","volume":"22","author":"HL McArthur","year":"2016","unstructured":"McArthur HL, Diab A, Page DB, et al. A pilot study of preoperative single-dose Ipilimumab and\/or Cryoablation in women with early-stage breast Cancer with comprehensive immune profiling. Clin Cancer Res. 2016;22:5729\u201337.","journal-title":"Clin Cancer Res"},{"key":"468_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/CJI.0b013e31821dcba5","volume":"34","author":"A Thakur","year":"2011","unstructured":"Thakur A, Littrup P, Paul EN, Adam B, Heilbrun LK, Lum LG. Induction of specific cellular and humoral responses against renal cell carcinoma after combination therapy with cryoablation and granulocyte-macrophage colony stimulating factor: a pilot study. J Immunother. 2011;34:457\u201367.","journal-title":"J Immunother"},{"key":"468_CR6","doi-asserted-by":"crossref","unstructured":"Scott Gettinger, Jungmin Choi, Katherine Hastings, Anna Truini, Ila Datar, Ryan Sowell, Anna Wurtz, Weilai Dong, Guoping Cai, Mary Ann Melnick, Victor Y. Du, Joseph Schlessinger, Sarah B. Goldberg, Anne Chiang, Miguel F. Sanmamed, Ignacio Melero, Jackeline Agorreta, Luis M. Montuenga, Richard Lifton, Soldano Ferrone, Paula Kavathas, David L. Rimm, Susan M. Kaech, Kurt Schalper, Roy S. Herbst, Katerina Politi, Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer. Cancer Discovery. 2017;7(12):1420\u20131435.","DOI":"10.1158\/2159-8290.CD-17-0593"},{"key":"468_CR7","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1158\/2159-8290.CD-16-0828","volume":"7","author":"V Anagnostou","year":"2017","unstructured":"Anagnostou V, Smith KN, Forde PM, et al. Evolution of Neoantigen landscape during immune checkpoint blockade in non-small cell lung Cancer. Cancer Discov. 2017;7:264\u201376.","journal-title":"Cancer Discov"},{"key":"468_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10501","volume":"7","author":"S Koyama","year":"2016","unstructured":"Koyama S, Akbay EA, Li YY, et al. Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints. Nat Commun. 2016;7:10501.","journal-title":"Nat Commun"},{"key":"468_CR9","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1080\/02656730902976807","volume":"25","author":"Z Chen","year":"2009","unstructured":"Chen Z, Shen S, Peng B, Tao J. Intratumoural GM-CSF microspheres and CTLA-4 blockade enhance the antitumour immunity induced by thermal ablation in a subcutaneous murine hepatoma model. Int J Hyperth. 2009;25:374\u201382.","journal-title":"Int J Hyperth"},{"key":"468_CR10","doi-asserted-by":"crossref","unstructured":"Uhlig J, Ludwig JM, Goldberg SB, Chiang A, Blasberg JD, Kim HS. Survival rates after thermal ablation versus stereotactic radiation therapy for stage 1 non-small cell lung Cancer: a National Cancer Database Study. Radiology. 2018;289:862\u201370.","DOI":"10.1148\/radiol.2018180979"},{"key":"468_CR11","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.1016\/j.ijrobp.2015.07.159","volume":"93","author":"EB Golden","year":"2015","unstructured":"Golden EB, Chachoua A, Fenton-Kerimian MB, Demaria S, Formenti SC. Abscopal responses in metastatic non-small cell lung Cancer (NSCLC) patients treated on a phase 2 study of combined radiation therapy and Ipilimumab: evidence for the in situ vaccination hypothesis of radiation. International Journal of Radiation Oncology*Biology*Physics. 2015;93:S66\u20137.","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"468_CR12","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","volume":"377","author":"SJ Antonia","year":"2017","unstructured":"Antonia SJ, Villegas A, Daniel D, et al. Durvalumab after Chemoradiotherapy in stage III non-small-cell lung Cancer. N Engl J Med. 2017;377:1919\u201329.","journal-title":"N Engl J Med"},{"key":"468_CR13","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.diii.2016.08.016","volume":"97","author":"T Baere de","year":"2016","unstructured":"de Baere T, Tselikas L, Catena V, Buy X, Deschamps F, Palussiere J. Percutaneous thermal ablation of primary lung cancer. Diagn Interv Imaging. 2016;97:1019\u201324.","journal-title":"Diagn Interv Imaging"},{"key":"468_CR14","doi-asserted-by":"publisher","first-page":"9137","DOI":"10.1007\/s13277-015-4126-3","volume":"36","author":"C Bastianpillai","year":"2015","unstructured":"Bastianpillai C, Petrides N, Shah T, Guillaumier S, Ahmed HU, Arya M. Harnessing the immunomodulatory effect of thermal and non-thermal ablative therapies for cancer treatment. Tumour Biol. 2015;36:9137\u201346.","journal-title":"Tumour Biol"},{"key":"468_CR15","doi-asserted-by":"publisher","first-page":"9251375","DOI":"10.1155\/2016\/9251375","volume":"2016","author":"A Mehta","year":"2016","unstructured":"Mehta A, Oklu R, Sheth RA. Thermal ablative therapies and immune checkpoint modulation: can Locoregional approaches effect a systemic response? Gastroenterol Res Pract. 2016;2016:9251375.","journal-title":"Gastroenterol Res Pract"},{"key":"468_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cryobiol.2008.10.126","volume":"58","author":"MS Sabel","year":"2009","unstructured":"Sabel MS. Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses. Cryobiology. 2009;58:1\u201311.","journal-title":"Cryobiology"},{"key":"468_CR17","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1158\/0008-5472.CAN-11-1782","volume":"72","author":"R Waitz","year":"2012","unstructured":"Waitz R, Solomon SB, Petre EN, et al. Potent induction of tumor immunity by combining tumor cryoablation with anti-CTLA-4 therapy. Cancer Res. 2012;72:430\u20139.","journal-title":"Cancer Res"},{"key":"468_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023621","volume":"6","author":"Z Zeng","year":"2011","unstructured":"Zeng Z, Shi F, Zhou L, et al. Upregulation of circulating PD-L1\/PD-1 is associated with poor post-cryoablation prognosis in patients with HBV-related hepatocellular carcinoma. PLoS One. 2011;6:e23621.","journal-title":"PLoS One"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40425-018-0468-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40425-018-0468-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40425-018-0468-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T13:43:17Z","timestamp":1601041397000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1186\/s40425-018-0468-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["468"],"URL":"https:\/\/doi.org\/10.1186\/s40425-018-0468-x","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"5 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Yes","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"147"}}